首页> 外文OA文献 >Efficacy and Safety of Insulin Glargine 300 Units/mL (Gla-300) Versus Insulin Glargine 100 Units/mL (Gla-100) in Children and Adolescents (6–17 years) With Type 1 Diabetes: Results of the EDITION JUNIOR Randomized Controlled Trial

【2h】

Efficacy and Safety of Insulin Glargine 300 Units/mL (Gla-300) Versus Insulin Glargine 100 Units/mL (Gla-100) in Children and Adolescents (6–17 years) With Type 1 Diabetes: Results of the EDITION JUNIOR Randomized Controlled Trial

机译：胰岛素龟甲300单位/ ml（GLA-300）的疗效和安全性与胰岛素和青少年（6-17岁）的胰岛素龟甲100个单位/ ml（GLA-100）（6-17岁）：Edition Junior随机对照试验的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Thomas Danne; William V. Tamborlane; Oleg A. Malievsky; Denise R. Franco; Tomoyuki Kawamura; Marek Demissie; Elisabeth Niemoeller; Harmonie Goyeau; Marek Wardecki; Tadej Battelino;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy and Safety of Insulin Glargine 300 Units/mL (Gla-300) Versus Insulin Glargine 100 Units/mL (Gla-100) in Children and Adolescents (6-17 years) With Type 1 Diabetes: Results of the EDITION JUNIOR Randomized Controlled Trial [J] . Diabetes care . 2020,第7期

机译：胰岛素龟甲300单位/ ml（GLA-300）的疗效和安全性与胰岛素和青少年（6-17岁）的胰岛素龟甲100个单位/ ml（GLA-100）（6-17岁）：Edition Junior随机对照试验的结果
2. Efficacy and safety of a morning injection of insulin glargine 300?units/mL versus insulin glargine 100?units/mL in adult patients with type 1 diabetes: A multicentre, randomized controlled trial using continuous glucose monitoring [J] . Pettus Jeremy, Gill Jasvinder, Paranjape Sachin, Diabetes, obesity & metabolism . 2019,第8期

机译：早晨注射胰岛素的疗效和安全性300？单位/ ml与胰岛素冰柱100？单位/ ml在1型糖尿病患者中：使用连续葡萄糖监测的多期，随机对照试验
3. New insulin glargine 300units/mL versus glargine 100 units/mL in people with type 2 diabetes using oral agents and basal insulin: Glucose control and hypoglycemia in a 6-month randomized controlled trial (Edition 2) [J] . Yki-J?rvinen,H., Bergenstal,R., Ziemen,M., Diabetes care . 2014,第12期

机译：使用口服药物和基础胰岛素的2型糖尿病患者中新的甘精胰岛素300单位/毫升与甘精胰岛素100单位/毫升的对比：一项为期6个月的随机对照试验（第2版）中的血糖控制和低血糖
4. Switching to insulin glargine 300 U/mL from other basal insulin analogues provides less 24-hour glucose variability in hospitalized patients with type 1 diabetes [C] . V.V. Klimontov, E.A. Koroleva, O.N. Fazullina International Multiconference Bioinformatics of Genome Regulation and StructureSystems Biology . 2018

机译：从其他基础胰岛素类似物转换为甘精胰岛素300 U / mL可使住院的1型糖尿病患者的24小时葡萄糖变异性降低
5. A 4-month randomized controlled clinical trial of adjuvant Exenatide or Pramlintide versus insulin alone in pediatric type 1 diabetes mellitus: Effect on glycemic control. [D] . Withycombe, Sarah Elizabeth. 2010

机译：儿科1型糖尿病患者中艾塞那肽或普兰林肽与单独使用胰岛素的4个月随机对照临床试验：对血糖控制的影响。
6. Efficacy and Safety of Insulin Glargine 300 Units/mL (Gla-300) Versus Insulin Glargine 100 Units/mL (Gla-100) in Children and Adolescents (6–17 years) With Type 1 Diabetes: Results of the EDITION JUNIOR Randomized Controlled Trial [O] . Thomas Danne, William V. Tamborlane, Oleg A. Malievsky, 2020

机译：1型糖尿病儿童和青少年（6至17岁）胰岛素甘草糖300单位/ mL（Gla-300）与胰岛素甘草碱100单位/ mL（Gla-100）的疗效和安全性：JUNIOR版的结果随机对照试验
7. New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 2 Diabetes Using Basal and Mealtime Insulin: Glucose Control and Hypoglycemia in a 6-Month Randomized Controlled Trial (EDITION 1) [O] . Matthew C. Riddle, Geremia B. Bolli, Monika Ziemen, 2014

机译：新的胰岛素冰柱300单位/ ml与冰柱100个单位/ ml有2型糖尿病使用基础和膳食胰岛素：葡萄糖对照和低血糖症在6个月的随机对照试验中（版本1）

Efficacy and Safety of Insulin Glargine 300 Units/mL (Gla-300) Versus Insulin Glargine 100 Units/mL (Gla-100) in Children and Adolescents (6–17 years) With Type 1 Diabetes: Results of the EDITION JUNIOR Randomized Controlled Trial

著录项

相似文献

相关主题

期刊订阅